NC-LENOVO
8.9.2021 06:02:11 CEST | Business Wire | Press release
Today, at its annual Tech World event, Lenovo announced an evolution in its consumption-based business model, introducing Lenovo TruScale , a new portfolio-spanning everything-as-a-service offering. This announcement is part of Lenovo’s continuing transformation for the next reality – a new era where consumers and business leaders need new solutions and technologies to face unprecedented change in business, education, living and beyond.
Expanding its TruScale brand beyond infrastructure services, Lenovo is bringing all of its as-a-service offerings under one umbrella to provide a truly global solution that makes everything from the pocket to the cloud available via a single contract framework. Lenovo TruScale embodies the company’s vision and transformation for the next reality – meeting the growing global demand for smarter technology amid a new era of hybrid working and learning.
“Digital transformation is accelerating faster than ever, and companies are struggling to keep pace with the speed of innovation. We hear from CIOs every day that their organizations’ technology needs are evolving every 12-18 months,” said Ken Wong, president of Solutions & Services Group. “With Lenovo TruScale, customers can expect one solution, one provider, one contract framework, and a single point of accountability for everything-as-a-service.”
Lenovo TruScale offers businesses of all sizes an everything-as-a-service platform with the flexibility they need to stay competitive with a scalable, cloud-like consumption model and predictable payment options for hardware and service inclusions. This transition to a fully integrated as-a-service strategy brings to life the company’s “One Lenovo” vision – addressing common business challenges and providing IT leaders with the performance and flexibility to pay-as-you-grow. With Lenovo TruScale, IT leaders’ infrastructure solutions are fully managed, giving customers the advantages of an on-premise cloud environment along with the peace of mind around data management in a hybrid environment.
Research shows the as-a-service market is growing at four times the overall IT services total addressable market. In three years, as-a-service models will represent 12% of enterprise x86 server spend and over 50% of new enterprise storage spend, growing at 40% CAGR and around 17% of commercial PC spend, up from 1% two years ago and growing at 50% CAGR.1
As the world shifts to a flexible “work, learn and connect-from-anywhere” model, organizations that embrace smarter technology designed for a hybrid reality will benefit from this transition. This requires flexibility in devices and work platforms, on-demand support when and where needed, and customizable solutions across the organization, benefits that many will recognize from Lenovo’s existing Device-as-a-Service solution. Now moving under the new TruScale umbrella, Lenovo DaaS will continue to help customers move to a Modern IT environment by combining the best end-to-end technology from across Lenovo with lifecycle services and support and convenient financing to deliver lower total cost of ownership.
Lenovo is building a new way to deliver as-a-service to the market and offer organizations ultimate flexibility in how they leverage their IT infrastructure, services and software. By forming strategic alliances with other market leaders, customers can get the public cloud experience with the security and control of an on-premises solution. As part of this new platform, Lenovo has joined with leading infrastructure partners Deloitte, VMWare and Intel, and DaaS security partners Absolute Software and SentinelOne to provide organizations with various dynamic offerings such as hybrid cloud solutions for Edge to Cloud environments, best-in-class managed security solutions and access to the most current storage infrastructure innovation, for the life of their data, with the ability to scale storage capacity on demand.
“Lenovo’s as-a-service approach helps meet the market's demand for responsive, reliable hybrid cloud operations. Put simply our organizations are helping companies grow their enterprises and mitigate risks to create more value and serve society better,” said Punit Renjen, CEO of Deloitte Global.
Learn more about TruScale’s latest offerings at Lenovo’s annual global innovation event, Tech World .
1 Gartner, IDC, Lenovo Market Intelligence
About Lenovo
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$60 billion revenue Fortune Global 500 company serving customers in 180 markets around the world. Focused on a bold vision to deliver smarter technology for all, we are developing world-changing technologies that power (through devices and infrastructure) and empower (through solutions, services and software) millions of customers every day and together create a more inclusive, trustworthy and sustainable digital society for everyone, everywhere. To find out more visit https://www.lenovo.com and read about the latest news via our StoryHub .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005942/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
